ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ELOVL2-AS1 suppresses tamoxifen resistance by sponging miR-1233-3p in breast cancer
Authors
Keywords
-
Journal
Epigenetics
Volume 18, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-11-01
DOI
10.1080/15592294.2023.2276384
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Behind the scenes: How RNA orchestrates the epigenetic regulation of gene expression
- (2023) Arianna Mangiavacchi et al. Frontiers in Cell and Developmental Biology
- MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
- (2023) Yao Tian et al. Advanced Science
- ELOVL2-AS1 inhibits migration of triple negative breast cancer
- (2022) Mingda Zhu et al. PeerJ
- Natural antisense transcripts as drug targets
- (2022) Olga Khorkova et al. Frontiers in Molecular Biosciences
- CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells
- (2022) Foruzan Moradi et al. LIFE SCIENCES
- Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence
- (2021) Yang Li et al. BREAST
- CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis
- (2020) Mengqi Lu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ZNRD1 and Its Antisense Long Noncoding RNA ZNRD1-AS1 Are Oppositely Regulated by Cold Atmospheric Plasma in Breast Cancer Cells
- (2020) Hyeon Woo Kim et al. Oxidative Medicine and Cellular Longevity
- CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis
- (2020) W. Ma et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance
- (2020) Jing Feng et al. Aging-US
- Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway
- (2019) Zhuo Li et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells
- (2019) Karolin Ebert et al. PLoS One
- lncRNA CYTOR promotes tamoxifen resistance in�breast cancer cells via sponging miR‑125a‑5p
- (2019) Yungyong Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- ChIP-seq analysis reveals alteration of H3K4 trimethylation occupancy in cancer-related genes by cold atmospheric plasma
- (2018) Seungyeon Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Cold atmospheric plasma restores tamoxifen sensitivity in resistant MCF-7 breast cancer cell
- (2017) Seungyeon Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
- (2017) Hongchao Pan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells
- (2016) Xinfeng Yu et al. BIOMEDICINE & PHARMACOTHERAPY
- Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
- (2016) Sungyul Lee et al. CELL
- Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer
- (2016) Y.-R. Liu et al. CLINICAL CANCER RESEARCH
- Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells
- (2016) WEI-GUANG LAN et al. ONCOLOGY REPORTS
- Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer
- (2016) Nai-si Huang et al. Oncotarget
- Regulators of genetic risk of breast cancer identified by integrative network analysis
- (2015) Mauro A A Castro et al. NATURE GENETICS
- A method for calculating probabilities of fitness consequences for point mutations across the human genome
- (2015) Brad Gulko et al. NATURE GENETICS
- LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
- (2015) X Xue et al. ONCOGENE
- miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A
- (2015) Kazuhiro Ikeda et al. Scientific Reports
- Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome
- (2015) Jill M. Siegfried et al. NEOPLASIA
- Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAcN-deacetylase/N-sulfotransferase-1 in human breast cancer
- (2014) Dong-Xu He et al. FEBS Journal
- Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells
- (2014) A M Redmond et al. ONCOGENE
- Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment
- (2012) D. H. Fagan et al. CANCER RESEARCH
- Expression profiling after induction of demethylation in MCF-7 breast cancer cells identifies involvement of TNF-α mediated cancer pathways
- (2012) Ju Hee Kim et al. MOLECULES AND CELLS
- Regulatory roles of natural antisense transcripts
- (2009) Mohammad Ali Faghihi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started